Dr. Paulo Pêgo-Fernandes apresenta estudo inédito no Congresso da STS

Abstract

The article approaches the presentation of Phase I of a trial on "Therapeutic endoscopic thoracic sympathectomy" by Dr. Paulo Pêgo. 15 patients with dilated cardiomyopathy and an ejection fraction below 40% participated in the trial, all in functional class II or III according New York Heart Association, with heart rate above 65 beats per minute, despite the correct use of beta-blockers, or because of intolerance of the patient to the drug. The procedure proved to be safe and no patients experienced adverse events related to the procedure in the perioperative period or during the initial 6 months of followup. According to Dr. Paulo Pêgo, the technique is easy to apply and shows to be safe in patients with severe heart failure, and could be an alternative to achieve sympathetic blockade in patients with severe dilated cardiomyopathy.